Combining ring segments and cross-linking yields good results

Article

Implantation of intracorneal ring segments (ICR) can be combined with a UV cross-linking procedure.

Implantation of intracorneal ring segments (ICR) can be combined with a UV cross-linking procedure, according to Omid Kermani and colleagues from a private eye clinic in Schildergasse, Germany.

Between 2005 and 2006, four keratoconic eyes underwent combined UV collagen cross-linking and ICR implantation. Following femtosecond laser assisted preparation of the corneal tunnel, ICRs were implanted. Two to six months later, if visual acuity (VA) and refraction were stable, a cross-linking procedure was performed.

ICR implantation resulted in an average best corrected visual acuity (BCVA) gain of two lines and an average uncorrected visual acuity (UCVA) gain of six lines. Collagen cross-linking did not change UCVA by three months postoperatively but BCVA increased by an average of one line. Although the results were stable initially, two eyes did demonstrate a decrease in effect from the ICR implants. In these cases, the single ring segment was replaced by two thicker segments, which helped improve VA by up to three lines.

The results demonstrate that ICR implantation and UV cross-linking can be combined, however, further studies are needed to show which combination of these procedures produces the best results.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.